Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 07'th Feb 2025
CAMBRIDGE, Mass., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-dr
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 07'th Feb 2025
THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell pl
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 07'th Feb 2025
NAARDEN, the Netherlands and MIAMI, Feb. 07, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutic
Applovin Emerges As Nasdaq 100's Dark Horse In A Market Fixated On Nvidia, Tesla, Palantir
08:37am, Friday, 07'th Feb 2025
In a market obsessed with the usual suspects—Nvidia Corp, Tesla Inc and Palantir Technologies Inc — one stock has been quietly stealing the show: AppLovin Corp. APP.
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 07'th Feb 2025
DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-b
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Friday, 07'th Feb 2025
SAN DIEGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicine
S&P 500, Nasdaq pop with Amazon set to highlight earnings rush
06:15am, Friday, 07'th Feb 2025
To get the latest market news check out finance.yahoo.com US stocks were mixed on Thursday in anticipation of Amazon's (AMZN) quarterly results, as investors assessed the earnings season so far and ey
Fusion Fuel Announces Decision by Nasdaq Hearings Panel
04:30pm, Thursday, 06'th Feb 2025
DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fusion Fuel Green PLC (Nasdaq: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of comprehensive energy engineering, advisory, an
Nasdaq 100: Amazon Stock Drops 4% After Hours Despite Strong Q4 Earnings Beat
04:24pm, Thursday, 06'th Feb 2025
Amazon beats Q4 estimates, but weak Q1 guidance sends shares down 4% after hours. Traders eye AWS growth and retail trends for market direction.
Wall Street today: S&P 500 and Nasdaq edge higher, Dow drops amid earnings focus
04:13pm, Thursday, 06'th Feb 2025
The US stock market was little changed on Thursday, with the S&P 500 and Nasdaq Composite holding modest gains while the Dow Jones Industrial Average slipped. Investors assessed a mixed set of corpora
TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC Deregistration
04:05pm, Thursday, 06'th Feb 2025
FOXBOROUGH, Mass., Feb. 6, 2025 /PRNewswire/ -- TFF Pharmaceuticals, Inc. (Nasdaq: TFFP) today announced that the Company has provided notification to The Nasdaq Stock Market, LLC ("Nasdaq") of its in
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Thursday, 06'th Feb 2025
SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializat
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Thursday, 06'th Feb 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare di
60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
02:07pm, Thursday, 06'th Feb 2025
60 Degrees Pharma closed a $1.075M registered direct offering, raising $2.118M YTD to fund operations. H.C. Wainwright & Co. acted as placement agent.
S&P 500, Nasdaq edge higher with Amazon set to highlight earnings rush
12:20pm, Thursday, 06'th Feb 2025
To get the latest market news check out finance.yahoo.com US stocks were mixed on Thursday in anticipation of Amazon's (AMZN) quarterly results, as investors assessed the earnings season so far and ey
